Literature DB >> 22846581

Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy.

David A Palma1, Suresh Senan.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22846581     DOI： 10.1016/j.cllc.2012.06.005

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  8 in total

1.  Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC.

Authors:  S Arcangeli; L Agolli; L Portalone; M R Migliorino; M G Lopergolo; A Monaco; J Dognini; M C Pressello; S Bracci; V Donato
Journal:  Br J Radiol       Date:  2015-02-03       Impact factor: 3.039

Review 2.  Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.

Authors:  Susanne Temming; Martin Kocher; Erich Stoelben; Lars Hagmeyer; De-Hua Chang; Konrad Frank; Khosro Hekmat; Juergen Wolf; Wolfgang W Baus; Robert Semrau; Christian Baues; S Marnitz
Journal:  Strahlenther Onkol       Date:  2017-08-15       Impact factor: 3.621

3.  Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours.

Authors:  Stefano Arcangeli; Lorenzo Falcinelli; Stefano Bracci; Alessandro Greco; Alessia Monaco; Jessica Dognini; Cinzia Chiostrini; Rita Bellavita; Cynthia Aristei; Vittorio Donato
Journal:  Br J Radiol       Date:  2017-03       Impact factor: 3.039

Review 4.  Innovative technologies in thoracic radiation therapy for lung cancer.

Authors:  Andrea Riccardo Filippi; Cristina Mantovani; Umberto Ricardi
Journal:  Transl Lung Cancer Res       Date:  2012-12

5.  Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Body Radiotherapy Treatment for Early-Stage Non-Small Cell Lung Cancer: A Propensity Score-Matching Analysis.

Authors:  Baiqiang Dong; Xuan Zhu; Zekai Shu; Yongling Ji; Fangxiao Lu; Jin Wang; Ming Chen
Journal:  Front Oncol       Date:  2020-11-10       Impact factor: 6.244

6.  Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.

Authors:  Julia Dreyer; Michael Bremer; Christoph Henkenberens
Journal:  Radiat Oncol       Date:  2018-11-03       Impact factor: 3.481

7.  Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.

Authors:  Baiqiang Dong; Jin Wang; Xuan Zhu; Yuanyuan Chen; Yujin Xu; Kainan Shao; Lei Zheng; Hangjie Ying; Ming Chen; Jianping Cao
Journal:  Radiat Oncol       Date:  2019-11-07       Impact factor: 3.481

8.  Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.

Authors:  Qingjin Qin; Anhui Shi; Ran Zhang; Qiang Wen; Tianye Niu; Jinhu Chen; Qingtao Qiu; Yidong Wan; Xiaorong Sun; Ligang Xing
Journal:  Thorac Cancer       Date:  2020-02-15       Impact factor: 3.500
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.